Literature DB >> 7334088

Increased blood viscosity in patients with Legg-Perthes disease: a preliminary report.

R G Kleinman, E E Bleck.   

Abstract

Based on studies by others, it appears that Legg-Perthes disease is an avascular necrosis of the femoral head due to occlusion of the blood supply. In an effort to delineate the pathogenesis of the disorder, we determined blood viscosity and percent platelet aggregation in 22 patients with Legg-Perthes disease and 21 control patients. Statistically significant higher blood viscosities were found in our patients with Legg-Perthes when compared with normals. No difference was found in the platelet aggregation studies. In accordance with Poiseuille's law, we propose that increased blood viscosity in patients with the affliction could lead to a diminution in blood flow to the capital femoral epiphysis, ultimately resulting in osteonecrosis and symptomatic manifestations of the disease.

Entities:  

Mesh:

Year:  1981        PMID: 7334088     DOI: 10.1097/01241398-198110000-00002

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  4 in total

Review 1.  What is the evidence supporting the prevention of osteoarthritis and improved femoral coverage after shelf procedure for Legg-Calvé-Perthes disease?

Authors:  Jason E Hsu; Keith D Baldwin; Moritz Tannast; Harish Hosalkar
Journal:  Clin Orthop Relat Res       Date:  2012-09       Impact factor: 4.176

Review 2.  Perthes' disease.

Authors:  P J Klisić
Journal:  Int Orthop       Date:  1984       Impact factor: 3.075

Review 3.  The epidemiology and demographics of legg-calvé-perthes' disease.

Authors:  Randall T Loder; Elaine N Skopelja
Journal:  ISRN Orthop       Date:  2011-09-05

Review 4.  Tissue Engineering Strategies for Treating Avascular Necrosis of the Femoral Head.

Authors:  Sumit Murab; Teresa Hawk; Alexander Snyder; Sydney Herold; Meghana Totapally; Patrick W Whitlock
Journal:  Bioengineering (Basel)       Date:  2021-12-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.